Public Health and Governance, Volume 8, Issue 2, 2010, pp. 4 - 29
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 30 - 46
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 47 - 56
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 57 - 72
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 63 - 67
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 68 - 86
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 87 - 95
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 96 - 100
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 101 - 108
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 108 - 118
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 113 - 116
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 117 - 118
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 119 - 120
Public Health and Governance, Volume 8, Issue 2, 2010, pp. 121 - 123
Słowa kluczowe: legislative process, executive regulations, sectoral health policy, health policy assessment methods, research instruments, health policy, public health, health policy evaluation, legislation, deliberative poll, deliberative democracy, participation, health policy, e-health, telemedicine, patient safety, electronic health record, personal health record, chronic care model, innovative health technologies, economic analysis, health technology assessment (HTA), limited financial resources, costs of health care, limited financial resources, costs of health care, electronic medical record, medical data, law regulations health technology assessment (hta), health care units, local government, ownership problems in health care, transformation, hospitals privatization, commercial law, commercial law companies, pharmaceutical innovation, pharmaceutical pricing, pharmaceutical reimbursement, pharmaceutical policy, pay-back, risk-sharing, responsibility, health care, modes of responsibility, determinants, fertility, United States, religion, education, migration, income, postnatal depression, public health, innowacja, leki biologiczne, nowe technologie, zdrowie seniorów, choroby nowotworowe, choroby kostno-szkieletowe, cukrzyca